Home » Diabetes » featured » Diabetes Introduction

Diabetes Introduction

February 17th, 2011 Diabetes, featured

A condition in which excessive amounts of some substances are excreted from the body. The term may refer  to either of two unrelated diseases, diabetes mellitus and diabetes insipidus. The word diabetes derives from  the Greek for siphon, a reference to the copious urine excretion that characterizes this affliction. In common  usage, the term diabetes is synonymous with diabetes mellitus.

Diabetes Mellitus

Diabetes mellitus is a disease of abnormal carbohydrate metabolism in which glucose cannot enter the body’s  cells and be utilized, and therefore remains in the blood in high concentrations. Mellitus is the Latin word meaning honey, and is applicable because the urine of patients with diabetes mellitus has a sweet taste,  distinguishing this disease from diabetes insipidus, in which large volumes of dilute, almost colorless and  tasteless urine are passed. In diabetes mellitus the excess sugar in the blood (hyperglycemia) leads to the  excretion of sugar in the urine (glycosuria), a cardinal diagnostic symptom. Glycosuria in turn causes the
excretion of large amounts of urine (polyuria), which results in dehydration and intense thirst (polydipsia).  Although blood glucose is high, it cannot enter the appetite-regulating cells of the hypothalamus; hunger is  therefore great, and the diabetic person tends to eat constantly (polyphagia). But because glucose cannot  enter and nourish the cells, body tissues are subjected to the equivalent of starvation; rapid weight loss  occurs, part of which is due to the excretion of water in urine. See also: Carbohydrate metabolism

Varieties

Diabetes mellitus appears in two varieties, each with its own cause: diabetes mellitus type I (formerly known  as juvenile onset diabetes), caused by deficiency of the pancreatic hormone insulin (whose chief function is  to promote the entry of glucose into cells); and diabetes mellitus type II (formerly known as maturity onset  diabetes), in which insulin is available but cannot be properly utilized.

Diabetes mellitus type I

Of the two forms of diabetes, type I is initially the more serious and less common, afflicting approximately 1  in every 600 children. The incidence varies among countries. The highest incidence is seen in Finland and  Sweden, and some of the lowest in Korea and Mexico. The United States and Canada are included among the  highest. Although it usually appears before the age of 20, type I diabetes can strike at any age. It is caused  by a significant shortage or complete lack of insulin secretion. The endocrine cells normally responsible for  insulin production are found in the pancreas, but have nothing to do with the ordinary digestive functions of  that organ. They occur as islands of endocrine tissue, called islets of Langerhans, scattered throughout the  substance of the pancreas.

The islets consist of at least three cell types, each of which secretes a different  hormone important in regulating carbohydrate metabolism. The alpha cells produce glucagon, which elevates  blood glucose; the beta cells produce insulin; and the delta cells produce somatostatin, a hormone that  appears to participate in controlling the activity of the alpha and beta cells. In type I diabetes the beta cells are destroyed, possibly by the attack of the body’s own immune system or  by virus infection; victims of type I require daily insulin injections to survive. Insulin must be injected rather  than taken orally because it is inactivated by the enzymes of the digestive system. Without insulin therapy, a  patient with type I diabetes will inevitably deteriorate into a condition of ketosis (presence in the blood of  ketone bodies, the metabolic intermediates of fat metabolism) and acidosis (dangerously acidic blood pH).

Ketoacidosis, as the combined condition is called, leads rapidly to coma and death in the untreated diabetic. When Frederick G. Banting and Charles H. Best succeeded in purifying insulin from animal pancreatic tissue
in 1921, type I diabetics were given their first chance at living a normal life-span. Today type I diabetics are  routinely treated by injections of insulin. Human insulin became increasingly available in the 1980s through  the use of recombinant deoxyribonucleic acid (DNA) technology. In this technique the gene specifying human  insulin is spliced into the chromosome of a bacterium, and the billions of progeny bacteria then produce  insulin as though it were one of their own bacterial proteins, thus serving as minifactories for the hormone.

The bacterium used to produce insulin is Escherichia coli. Another DNA technique for producing insulin uses  yeast instead of E. coli. Up to the early 1980s, insulin was extracted from cattle and pigs. This “foreign”  insulin is still used, but has some unwanted side effects not seen or rarely seen with human insulin, therefore  making human insulin the treatment of choice. One of the most important characteristics of insulin produced  by genetic engineering, other than its being identical to human pancreatic insulin, is its limitless
availability. See also: Genetic engineering; Insulin; Pancreas

Diabetes mellitus type II

Type II is the more common form of diabetes mellitus, accounting for 8 out of every 10 cases. It usually  appears after the age of 30, although an uncommon variant called type II diabetes of the young occasionally  occurs in obese children and teenagers. The initial symptoms of type II diabetes are much less noticeable  than those of type I, and the characteristic triad of polyuria, polydipsia, and polyphagia may even be entirely  absent. For this reason, type II diabetes can exist undetected for dangerously long periods. Victims are not  prone to the ketoacidosis and coma that threaten type I patients, and their disease can usually be managed  without insulin injections. Thus two other names for type II diabetes are nonketosis-prone diabetes and non- insulin-dependent diabetes.

Whereas type I diabetes is a disease of insulin shortage, victims of type II diabetes usually have insulin in  their bloodstream. In fact, insulin levels in type II diabetics are sometimes even higher than those in  nondiabetic individuals. However, since the cells of a type II patient do not respond to insulin by taking in  and utilizing blood glucose as normal cells would, the type II diabetic may have hyperglycemia in spite of  high insulin levels. The probable reason for this defect is that the cells have specific receptor molecules on  their surface membranes whose job is to recognize insulin and trigger the biochemical steps leading to  glucose uptake and utilization. Interestingly, the number of insulin receptors on cells can be changed by  gaining or losing body weight; the more body fat a person carries, the fewer insulin receptors there will be on  the cells. This may explain why type II diabetes is mainly a disease of the obese, and why weight reduction is  such effective therapy.

High glucose levels also decrease the number of insulin receptors; normalizing  glucose levels is thus of utmost importance. The most important treatment for most cases of type II diabetes consists of exercise and weight reduction,  which will return glucose metabolism to normal in 9 out of 10 cases. Because the cells of type II diabetics  lack responsiveness to their own insulin, insulin injection therapy is used for some of these cases.  Approximately 10% of all type II patients must use insulin.

This percentage appears to more than double in  Black, Latino, Native American, or other minority patients living in the United States. In addition, a family of  drugs known as oral hypoglycemic agents is often used in treating the disease. These drugs, including  tolbutamide, chlorpropamide, acetohexamide, and tolazamide, lower blood glucose by stimulating the  pancreatic cells to release insulin, and by augmenting insulin’s effect on the cells of the body.

All of these  drugs are known as first-generation sulfonylureas. However, there are other drugs with the same basic  molecule but with chemical changes in their structure; these are called second-generation sulfonylureas. This  group of drugs is safe if properly used and is effective in many cases if used in conjunction with proper diet and exercise programs.

Share this post to your friends!
facebook
twitter
stumbleupon
Delicious
reddit
Digg

Related Post to Diabetes Introduction

Pre-Launch Aranaiya.Com

February 11, 2011
Welcome heresdfgsdg...

Fairbet88.com dukung fairplay EURO 2012

June 6, 2012
Fairbet88.com dukung fairplay EURO 2012. EURO 2012 tinggal menghitung hari saja. Kita akan sama-sama menyaksikan Perhelatan akbar di bidang olahraga ini. Semua siap-siap untuk bersorak...

Knowledge About Diabetes Management and Supplies

November 16, 2011
Diabetes Management and Supplies Aranaiya.Com. How to Acquire Knowledge About Diabetes Management and Supplies ?. Diabetes is actually a chronic sickness that does not...

Diabetes Introduction

February 17, 2011
A condition in which excessive amounts of some substances are excreted from the body. The term may refer  to either of two unrelated diseases,...